a16z Perennial Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,993
Closed -$393K 72
2026
Q1
$393K Hold
1,993
0.03% 87
2025
Q4
$366K Hold
1,993
0.03% 95
2025
Q3
$306K Buy
+1,993
New +$302K 0.02% 89

Other funds holding AZN

a16z Perennial Management's AZN Position: Q2 2026 in Review

a16z Perennial Management sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 1,993 shares — an estimated $393K sold.

a16z Perennial Management first reported a position in AZN in Q3 2025 and held it in 3 quarters. The position peaked at $393K in Q1 2026. 655 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • a16z Perennial Management reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • a16z Perennial Management sold 1,993 AstraZeneca shares in Q2 2026, an estimated $393K.
  • a16z Perennial Management first reported a position in AstraZeneca in Q3 2025 and held it in 3 quarters.
  • a16z Perennial Management's AstraZeneca position peaked at $393K in Q1 2026.
  • 655 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on a16z Perennial Management's 13F filing for Q2 2026, filed 24 Jul 2026.